Risk Factors for Natural Cause Mortality in a Cohort of 1494 Persons with Serious Mental Illness

Time Trends in the Use of Coronary Procedures, Guideline-Based Therapy, and All-Cause Mortality following the Acute Coronary Syndrome in Patients with Schizophrenia

(2020) Rubina Attar et al.   CARDIOLOGY

Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland

(2020) Nicola Torrance et al.   BRITISH JOURNAL OF ANAESTHESIA

Predicting mortality from 57 economic, behavioral, social, and psychological factors

(2020) Eli Puterman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness

(2020) Gail L. Daumit et al.   JAMA Network Open

Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review

(2019) Saeed Ahmed et al.   Frontiers in Psychiatry

Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation

(2019) Zoltan Ungvari et al.   Frontiers in Genetics

Atypical Immune Response to Epstein-Barr Virus in Major Depressive Disorder

(2019) Lorraine Jones-Brando et al.   JOURNAL OF AFFECTIVE DISORDERS

Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort study

(2019) Israel Krieger et al.   SCHIZOPHRENIA RESEARCH

Natural cause mortality in persons with serious mental illness

(2018) F. Dickerson et al.   ACTA PSYCHIATRICA SCANDINAVICA

Development and Validation of a High-Quality Composite Real-World Mortality Endpoint

(2018) Melissa D. Curtis et al.   HEALTH SERVICES RESEARCH

Increasing mortality gap for patients diagnosed with bipolar disorder-A nationwide study with 20 years of follow-up

(2018) Pernille Staudt Hansen et al.   BIPOLAR DISORDERS

Can Better Cardiovascular Care Close the Mortality Gap for People With Schizophrenia?

(2018) Benjamin G. Druss   JAMA Psychiatry

Mortality and life expectancy in persons with severe unipolar depression

(2016) Thomas Munk Laursen et al.   JOURNAL OF AFFECTIVE DISORDERS

Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors

(2016) Faith Dickerson et al.   SCHIZOPHRENIA RESEARCH

The prevention of diabetes and cardiovascular disease in people with schizophrenia

(2015) R. I. G. Holt   ACTA PSYCHIATRICA SCANDINAVICA

Premature Mortality Among Adults With Schizophrenia in the United States

(2015) Mark Olfson et al.   JAMA Psychiatry

Mortality in Mental Disorders and Global Disease Burden Implications

(2015) Elizabeth Reisinger Walker et al.   JAMA Psychiatry

Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder

(2014) A. Eden Evins et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies

(2012) Laura W. Harris et al.   PSYCHONEUROENDOCRINOLOGY

Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia

(2012) Faith Dickerson et al.   SCHIZOPHRENIA RESEARCH

Association of Hypertension Treatment and Control With All-Cause and Cardiovascular Disease Mortality Among US Adults With Hypertension

(2009) Q. Gu et al.   AMERICAN JOURNAL OF HYPERTENSION